Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-14-001663
Filing Date
2014-02-06
Accepted
2014-02-06 17:25:25
Documents
1
Period of Report
2014-02-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 22916
  Complete submission text file 0001437749-14-001663.txt   24437
Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-456-7800
Furiex Pharmaceuticals, Inc. (Issuer) CIK: 0001484478 (see all company filings)

EIN.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FURIEX PHARMACEUTICALS, INC. 3900 PARAMOUNT PARKWAY, SUITE 150 MORRISVILLE NC 27560
Business Address
Almenoff June Sherie (Reporting) CIK: 0001492647 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34641 | Film No.: 14581106